Supported by robust data from numerous clinical trials, low-tidal-volume ventilation is now standard-of-care in managing patients with acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS).
Participants in this study were 100 patients/surrogates and their physicians in a 26-bed medical ICU located in an academic medical center.
A new orally effective targeted therapy for the treatment of non-small cell lung cancer (NSCLC) has been approved by the FDA. Crizotinib is a receptor tyrosine kinase inhibitor including anaplastic lymphoma kinase (ALK).
Eating out has increased in the general population, and is associated with increased body mass index. Indeed, United States data suggest that more than one-third of all daily calories are provided from restaurants.
